β3Gn-T7 Activators
β3Gn-T7 Activators are a diverse set of chemical compounds that enhance the enzyme's activity by influencing various cellular pathways and biochemical processes involved in glycosylation. Forskolin, by raising adenylate cyclase activity, leads to an increase in cAMP levels, activating PKA, which in turn could enhance the glycosylation capacity of β3Gn-T7 through phosphorylation of proteins that regulate glycosyltransferase functions. The preservation of cAMP levels by IBMX, through inhibition of phosphodiesterases, also contributes to sustained PKA activity, which is hypothesized to augment β3Gn-T7's role in glycosylation. PMA stimulates protein kinase C, which may enhance β3Gn-T7's activity by phosphorylation of proteins within its regulatory framework. The direct involvement of MnCl2 as a cofactor for β3Gn-T7 implies its potential to directly boost the enzyme's activity.
The substrate availability is another pivotal factor, as demonstrated by UDP-GlcNAc, which provides the necessary sugar donor for β3Gn-T7's glycosyltransferase function, suggesting that an increase in substrate concentration could enhance enzyme activity. Sphingosine-1-phosphate (S1P) activates signaling that includes the MAPK/ERK pathway, which can indirectly escalate β3Gn-T7's functional activity by modulating cellular glycosylation patterns. The modulation of intracellular calcium levels by compounds like A23187 and Thapsigargin may indirectly upregulate β3Gn-T7 by influencing calcium-dependent signaling. Compounds such as Tunicamycin and Brefeldin A disrupt normal glycosylation processing, potentially triggering a cellular compensatory mechanism that enhances the activity of β3Gn-T7 to maintain glycosylation functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn activate PKA. PKA phosphorylates multiple targets, leading to enhanced glycosylation activities, indirectly increasing the functional activity of β3Gn-T7. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which prevents cAMP degradation, thereby enhancing PKA activity and potentially upregulating the glycosylation process where β3Gn-T7 is involved. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate proteins that are involved in the regulation of glycosyltransferases like β3Gn-T7, leading to its enhanced functional activity. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Manganese chloride is a cofactor that activates certain glycosyltransferases. As a cofactor for β3Gn-T7, MnCl2 may enhance its enzymatic activity directly. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P engages S1P receptors, activating downstream signaling including MAPK/ERK pathway which may indirectly enhance the functional activity of glycosyltransferases like β3Gn-T7 by altering cellular glycosylation patterns. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 increases intracellular calcium, which can activate pathways influencing glycosyltransferase activity. Enhanced calcium levels may indirectly upregulate β3Gn-T7's function in the cell. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin elevates intracellular calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). Elevated calcium can enhance β3Gn-T7 activity by affecting calcium-dependent signaling pathways. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, causing cellular stress that can lead to upregulation of other glycosylation pathways, potentially enhancing the activity of alternative glycosyltransferases like β3Gn-T7. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi structure, which may trigger a cellular response that compensates by upregulating glycosyltransferases such as β3Gn-T7 to maintain glycosylation functions. | ||||||